Nektar Therapeutics
(NKTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -250,008 | -213,756 | -186,835 | -81,041 | -97,400 |
| Depreciation Amortization | 40,385 | 26,951 | 14,635 | 6,239 | 10,120 |
| Accounts receivable | -4,238 | -1,273 | -700 | -2,169 | -964 |
| Other Working Capital | 8,037 | 143,309 | 158,125 | 61,717 | 3,620 |
| Other Operating Activity | 155,050 | 1,753 | 1,180 | 2,401 | 48,884 |
| Operating Cash Flow | $-50,774 | $-43,016 | $-13,595 | $-12,853 | $-35,740 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 39,335 | 26,013 | 185,402 | -24,525 | -242,374 |
| PPE Investments | -34,321 | -26,559 | -18,286 | -10,119 | -53,850 |
| Net Acquisitions | -82,051 | -82,051 | -82,051 | -14,805 | 0 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -2,292 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -3,516 |
| Investing Cash Flow | $-77,037 | $-82,597 | $85,065 | $-49,449 | $-299,740 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 17,653 | 15,119 | 11,424 | 3,699 | 461,487 |
| Debt Repayment | -1,089 | -593 | -378 | -186 | -50 |
| Common Stock Issued | 6,049 | 5,075 | 4,614 | 2,819 | 17,322 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -40,689 |
| Financing Cash Flow | $22,613 | $19,601 | $15,660 | $6,332 | $438,070 |
| Beginning Cash Position | 136,012 | 136,012 | 136,012 | 136,012 | 33,430 |
| End Cash Position | 30,814 | 30,000 | 223,142 | 80,042 | 136,010 |
| Net Cash Flow | $-105,198 | $-106,012 | $87,130 | $-55,970 | $102,580 |
| Free Cash Flow | |||||
| Operating Cash Flow | -50,774 | -43,016 | -13,595 | -12,853 | -35,740 |
| Capital Expenditure | -34,321 | -26,559 | -18,286 | -10,119 | -53,850 |
| Free Cash Flow | -85,095 | -69,575 | -31,881 | -22,972 | -89,590 |